Open AccessOriginal Article Tranexamic Acid Mesotherapy Versus Triple Combination Cream in Melisma
DOI:
https://doi.org/10.51253/pafmj.v75iSUPPL-5.9209Keywords:
Hydroquinone, Intralesional, Kligman’s formula, Melasma, Mesotherapy, Tranexamic acid, Triple combination cream.Abstract
Objective: To compare the efficacy of Tranexamic acid mesotherapy versus combination of hydroquinone, tretinoin, and fluocinolone cream (Triple cream) for melisma.
Study Design: Randomized controlled trial (Iranian Registry of Clinical Trials = 20210823052264N1)
Place and Duration of Study: Department of Dermatology, PNS Shifa Hospital Karachi, Pakistan from Mar 2022 to Aug 2022.
Methodology: A total of 58 patients were divided randomly into two groups, A (29 patients) and B (29 patients). Group A patients received sessions of intalesional tranexamic acid 50mg/ml every 2 weeks. Group B patients were treated once nightly with Triple combination cream. Total Period of treatment was for twelve weeks for each patient. Measurement of Melasma Area Severity Index (MASI) Scores for both groups were calculated at 0, 4, 8, and 12 weeks. Final response was labelled at 12 weeks by comparing mean MASI reduction in both groups. SPSS, version 28 was used for data analysis and p<0.05 was considered significant.
Results: At the end of study comparison was made of Mean reduction of MASI Score for both groups, significant reduction was noted in mean score from 7.73±1.43 to 4.30±1.34 (44.37%) in group A Tranexamic acid as compared to decrease in scores in group B Triple combination cream from 7.90±1.11 to 5.20±1.39 (34.18%) p-value 0.081.
Conclusion: Tranexamic acid mesotherapy can be safe, effective and promising treatment option for melasma. It leads to better results, and lesser side effects than topical triple cream.
Downloads
References
1. Rahman A, Basit A, Mohsin S, Ahmed N, Tahir M, Ishfaq A. Quality of Life of Melasma Patients in Pakistan. PAFMJ 2022; 72(1): 307-310.
2. McKesey J, Tovar-Garza A, Pandya AG. Melasma Treatment: An Evidence-Based Review. Am J Clin Dermatol 2020; 21(2): 173-225. https://doi.org/10.1007/s40257-019-00488-w
3. Pazyar N, Yaghoobi R, Zeynalie M, Vala S. Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma. Clin Cosmet Investig Dermatol 2019; 12: 115-122.
https://doi.org/10.2147/CCID.S191964
4. Rajanala S, Maymone MBC, Vashi NA. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J 2019; 25(10): 13030/qt47b7r28c.
5. Khan KN, Ahmed N, Salik KM, Mahboob M, Niaz F, Panhwar M. Frequency of Hypothyroidism in Patients with Melasma in a Tertiary Care Hospital. InMed. Forum 2021 Dec (Vol. 32, No. 12, p. 133).
6. Colferai MMT, Miquelin GM, Steiner D. Evaluation of oral tranexamic acid in the treatment of melasma. J Cosmet Dermatol 2018 Dec 9. https://doi.org/10.1111/jocd.12830
7. Zhou LL, Baibergenova A. Melasma: systematic review of the systemic treatments. Int J Dermatol 2017; 56(9): 902-908.
https://doi.org/10.1111/ijd.13578
8. Torok, Helen M. “A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.” American journal of clinical dermatology vol. 7,4 (2006): 223-230.
https://doi.org/10.2165/00128071-200607040-00003
9. Riaz S, Ahmed N, Anwar A, Tahir M, Yousaf F, Kausar S. Comparison of 4% Topical Hydroquinone versus Combination of Oral Tranexamic Acid and 4% Topical Hydroquinone in the Treatment of Epidermal Melasma. Pakistan Journal of Medical and Health Sciences. 15. 3406-3409.
https://doi.org/10.53350/pjmhs2115103406
10. Kim, Hyun Jung . “Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.” Acta dermato-venereologica vol. 97,7 (2017): 776-781.
https://doi.org/10.2340/00015555-2668
11. Pazyar N, Molavi SN, Hosseinpour P, Hadibarhaghtalab M, Parvar SY, Dezfuly MB. Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: A split-face comparative trial. Health Sci Rep 2022; 5(2): e537.
https://doi.org/10.1002/hsr2.537
12. Ahmad Nasrollahi S, Sabet Nematzadeh M, Samadi A, Ayatollahi A, Yadangi S, Abels C et al. Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin. Clin Cosmet Investig Dermatol 2019; 12: 437-444.
https://doi.org/10.2147/CCID.S202285
13. Perper M, Eber AE, Fayne R, Verne SH, Magno RJ, Cervantes J et al. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature. Am J Clin Dermatol 2017; 18(3): 373-381.
https://doi.org/10.1007/s40257-017-0263-3
14. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg 2006; 32(5): 626-631.
https://doi.org/10.1111/j.1524-4725.2006.32133.x
15. Shetty, Vinma & Shetty, Monisha. (2018). Comparative study of localised intradermal microinjection of tranexamic acid and oral tranexamic acid for the treatment of melasma. International Journal of Research in Dermatology. 4. 363. 10.18203/issn.2455-4529. IntJResDermatol20183159.
16. Saki N, Darayesh M, Heiran A. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. J Dermatolog Treat 2018; 29(4): 405-410.
https://doi.org/10.1080/09546634.2017.1392476
17. Basit A, Rahman A, Uddin R. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma. J Ayub Med Coll Abbottabad 2021; 33(2): 293-298.
18. Patil, ShrutiS & Deshmukh, AshishR. (2019). Comparative study of efficacy of intradermal tranexamic acid versus topical tranexamic acid versus triple combination in melasma. Pigment International. 6. 84.
10.4103/Pigmentinternational.Pigmentinternational_19_19.
19. Hawwam SA, Ismail M, El-Attar YA. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation. Lasers Med Sci 2022; 37(4): 2193-2201.
https://doi.org/10.1007/s10103-021-03483-y
20. Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M. Safety and efficacy of mesotherapy in the treatment of melasma: A review article. J Cosmet Dermatol 2022; 21(1): 118-129.
https://doi.org/10.1111/jocd.14644
21. Elfar, Nashwa & El Maghraby, Gamal. (2015). Efficacy of Intradermal Injection of Tranexamic Acid, Topical Silymarin and Glycolic Acid Peeling in Treatment of Melasma: A Comparative Study. jornal of Clinical and Experimental Dermatol research 6. 1-7. https://doi.org/10.4172/2155-9554.1000280
22. Ferreira Cestari T, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol 2007; 6(1): 36-39.
https://doi.org/10.1111/j.1473-2165.2007.00288.x.
23. Lueangarun S, Sirithanabadeekul P, Wongwicharn P, Namboonlue C, Pacharapakornpong S, Juntongjin P et al. Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up. J Clin Aesthet Dermatol 2020; 13(8): 36-39. Epub 2020 Aug 1. PMID: 33178380; PMCID: PMC7595366.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Najia Ahmed, Muhammad Rahim, Moizza Tahir, Tariq Mehmood Malik, Shafia Memon, Saira Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
